Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SIOResin is a dental materials company focused on the development and commercialization of advanced antimicrobial and anti-biofilm resin technologies. The company's core innovation is a proprietary resin system that incorporates antimicrobial agents directly into the polymer matrix, designed to prevent secondary caries and improve the longevity of dental restorations. Their products are used in various dental applications, including composites, adhesives, and sealants, providing a proactive approach to oral health by inhibiting bacterial growth at the restoration interface. SIOResin aims to transform restorative dentistry by offering materials that not only restore tooth structure but also actively protect it from future decay.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SIOResin.